文献速递妇科生殖医学

妇科三大恶性肿瘤的保留生育功能手术综述

Fertility-sparing Surgery for Patients with Cervical, Endometrial, and Ovarian Cancers.
PubMed 文献 · J Minim Invasive Gynecol · 2020-12-26

本文综述宫颈癌、子宫内膜癌和卵巢癌的保留生育功能治疗推荐与创新研究。早期宫颈癌可行冷刀锥切、保留卵巢的简单子宫切除或根治性宫颈切除加永久环扎;子宫内膜癌可用孕激素治疗并每3-6个月内膜取样;卵巢癌可行单侧或双侧附件切除。保留生育管理的前列腺无进展生存和总生存率可接受,对生活影响小于更根治手术。

要点

  • 早期宫颈癌保留生育手术包括冷刀锥切、保留卵巢的简单子宫切除或根治性宫颈切除加永久环扎。
  • 子宫内膜癌孕激素治疗需每3-6个月内膜取样,消退后可停药尝试妊娠。
  • 卵巢癌保留生育手术为单侧或双侧附件切除,高危组织学或较晚期需辅助化疗,卵巢衰竭风险3%-10%。

核心结论

  • 妇科癌症的保留生育管理与前卫生存和总生存率可接受相关,且比更根治手术对生活影响更小。

研究设计与样本

  • 综述,聚焦宫颈癌、子宫内膜癌和卵巢癌三大妇科癌症的保留生育治疗现有推荐与创新研究。

主要发现

  • 早期宫颈癌保留生育手术包括冷刀锥切、保留卵巢的简单子宫切除或根治性宫颈切除加永久环扎。
  • 局部晚期宫颈癌放疗前卵巢移位有助于保留卵巢功能。
  • 子宫内膜癌保留生育治疗包括孕激素治疗并每3-6个月内膜取样,消退后可停药尝试妊娠。
  • 子宫内膜癌也可考虑保留卵巢的子宫切除,通过辅助生殖技术和代孕实现生育。
  • 卵巢癌保留生育手术包括单侧或双侧附件切除,根据肿瘤组织学决定淋巴结清扫和分期。

关键数值与推荐

  • 子宫内膜癌孕激素治疗期间每3-6个月进行内膜取样。
  • 卵巢癌高危组织学或较高早期疾病推荐辅助化疗,卵巢衰竭风险3%至10%。
  • 早期卵巢恶性肿瘤卵母细胞或胚胎冷冻保存仍在研究中。

临床怎么用

  • 对合适选择的患者,保留生育选项可减少救命癌症治疗对生育的影响。
  • 早期宫颈癌可根据分期选择冷刀锥切、保留卵巢的简单子宫切除或根治性宫颈切除加永久环扎。
  • 局部晚期宫颈癌放疗前可考虑卵巢移位以保留卵巢功能。
  • 子宫内膜癌孕激素治疗需定期内膜取样监测,消退后可尝试妊娠。
  • 卵巢癌保留生育手术需根据组织学决定是否行淋巴结清扫和分期,高危者辅助化疗需告知卵巢衰竭风险。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: Nearly 10% of the 1.3 million women living with a gynecologic cancer are aged <50 years. For these women, although their cancer treatment can be lifesaving, it's also life-altering because traditional surgical procedures can cause infertility and, in many cases, induce surgical menopause. For appropriately selected patients, fertility-sparing options can reduce the reproductive impact of lifesaving cancer treatments. This review will highlight existing recommendations as well as innovative research for fertility-sparing treatment in the 3 major gynecologic cancers. TABULATION, INTEGRATION, AND RESULTS: For early-stage cervical cancers, fertility-sparing surgeries include cold knife conization, simple hysterectomy with ovarian preservation, or radical trachelectomy with placement of a permanent cerclage. In locally advanced cervical cancer, ovarian transposition before radiation therapy can help preserve ovarian function. For endometrial cancers, fertility-sparing treatment includes progestin therapy with endometrial sampling every 3 to 6 months. After cancer regression, progestin therapy can be halted to allow attempts to conceive. Hysterectomy with ovarian preservation can also be considered, allowing for fertility using assisted reproductive technology and a gestational carrier. For ovarian cancers, fertility-sparing surgery includes unilateral salpingo-oophorectomy or bilateral salpingo-oophorectomy (with lymphadenectomy and staging depending on tumor histology). With higher-risk histology or higher early-stage disease, adjuvant chemotherapy is recommended-however, this carries a 3% to 10% risk of ovarian failure. Use of oocyte or embryo cryopreservation in patients with early-stage ovarian malignancy remains an area of ongoing research. CONCLUSION: Overall, fertility-sparing management of gynecologic cancers is associated with acceptable rates of progression-free survival and overall survival and is less life-altering than more radical surgical approaches.

来源:J Minim Invasive Gynecol,查看原文。版权归原作者所有。

引用

  1. Kohn JR, Katebi Kashi P, Acosta-Torres S, et al. Fertility-sparing Surgery for Patients with Cervical, Endometrial, and Ovarian Cancers. J Minim Invasive Gynecol. 2020. PMID: 33373729. doi:10.1016/j.jmig.2020.12.027

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。